Docket Room.
A 538·NJ·house

"Pharmaceutical Representative Licensing Act."

In CommitteeFiled Jan 13, 2026
Sponsor: Bob Auth (R)
Latest Action

Introduced First Reading Assembly Referred to ARP

Jan 13, 2026

Email me when A 538 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track A 538. By continuing you agree to the Terms and Privacy Policy.

Legislative status

  1. Introduced
  2. In Committee
  3. Reported by Committee
  4. Floor Vote Scheduled
  5. Passed One Chamber
  6. Passed Both Chambers
  7. Sent to Executive
  8. Signed into Law

Summary

The bill creates a licensing system for individuals who market prescription drugs, biologics, or devices to doctors, placing the State Board of Medical Examiners in charge. Applicants must be at least 18, of good moral character, complete a board‑approved education course and pay the required fees. Licensed reps must renew every two years, complete continuing education, and report their contacts, gifts, and payments to practitioners.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about A 538

3 free questions a day, no account

History

  1. Introduced, Referred to Assembly Regulated Professions Committee

Sponsors

  • Bob Auth (R) · sponsor
  • Auth, Robert

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when A 538 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track A 538 free

Or ask your AI assistant about A 538 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice